Advantis Corp.’s Pet Division Making Progress Toward Debut

NEWPORT BEACH, CA, Dec. 10, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – ADVANTIS CORPORATION (OTC PINK: ADVT) announced today that it has entered into negotiations with potential manufacturers of its products for the Pet Division. Advantis has also identified its Orange County, California location that it plans to move some of its own manufacturing operations into.

Advantis announced earlier this year that it partnered with a trusted and well-known personality (Dr. Geoff) in the pet supplement industry. Dr. Geoff was perfecting a CBD based family of compounds that help with several ailments, pain/behavioral management, and other health issues that we and our pets cope with.  Advantis hopes to firmly establish itself in the multi-billion dollar pet supplement industry through marketing agreements with some of the largest pet food and supplement distributors in the world. Advantis CEO, Darren Cherry, says they are currently meeting with potential manufacturers of its pet products and added, “We’ve gone through extensive testing and know we have the demand to establish a growing long-term manufacturing agreement.” Cherry said that he was introduced to the cost saving options of the co-packing solution at the Las Vegas MJBIZCON. “We were initially planning on setting up the system ourselves for creating the products, but that would have been much costlier, and it would not have kept up with the continuous growing demand that we anticipate,” Cherry explained. “A couple of these manufacturers have their own needs and distribution channels that can create additional synergies between our companies, as well.” Cherry added that while the Pet Division is about to create a brand-new revenue stream for Advantis, the expansion to the licensed space in Orange County will allow the company’s growing Amster-Can business to, “have everything in place to more properly scale our business model.”

Cherry says that Phase One of their Orange County expansion is making great progress. “The site has been selected, and we are initializing the steps of the permitting process so we can market our own products directly to recreational dispensaries. We are working on putting the pieces together, like the track and trace software we’ll put in place, thanks to a connection made through our partners at N2Pack. Partnering with StrainRX is going to revolutionize the way people choose their cannabis solution, and significantly increase our own marketability in the process. I can’t tell you how much I love what they do and the genuine service they supply to the marketplace.” Cherry concluded by saying that, “Exciting announcements are coming for 2019. We continue growing our revenue with our current clients and acquire new ones with unknown potential every week. The next three years will see Advantis position itself and grow to be a central player across the cannabis industry.”

Advantis wishes to thank Investors Hangout for mentioning the company in their podcast.

Links to Advantis pictures and websites can be found on Facebook and Instagram pages, and at advantiscorp.com, rosin6.com, elixicure.com, and amstercan.com. 

About Advantis Corporation

Advantis Corporation (ADVT) focuses on the development of innovative products that supply the medical, research, and pharmaceutical industries. The company additionally establishes partnerships with businesses that develop and sell proprietary pain management, and consumer products and services. 

Forward Looking Statements: This news release contains forward-looking statements made by ADVANTIS CORPORATION. All such statements included in this press release, other than statements of historical fact, are forward-looking statements. Although management believes that the expectations reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have been correct. Actual results may differ materially from those indicated by these statements. The following risk factors, among others, could cause actual results to differ materially from those described in any forward- looking statements. These risks and uncertainties include, but are not limited to, economic conditions, changes in the law or regulations, demand for products of the Company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements. Forward- looking statements are typically identified by the words: believe, expect, anticipate, intend, estimate, and similar expressions or which by their nature refer to future events. The Company is not entitled to rely on the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 because it is not registered under either Act.